orcrb

Public Engagement

See our upcoming events

FB-small

Jenner Institute

Twitter_small

@JennerInstitute

News

CNN Frontiers interview with Adrian Hill

Posted 03/06/2016

(CNN) As director of the Jenner Institute, Hill is creating a well-crafted "potion" of ingredients which, when combined inside a vaccine, could prepare our immune system to attack biological invaders. His formulation could one day form the foundation to protect humans from a range of diseases including malaria, HIV and tuberculosis. It's being harnessed to design a new class of vaccine, unlike any other in use today, with an end goal of disease elimination. "This is being assessed widely for use in cancer, Hepatitis C, and we've used it in Ebola and HIV," says Hill. "There are 8 different diseases where [this] approach is in clinical trial."

Genes that increase children's risk of blood infection identified

Posted 27/05/2016

A team led by Oxford University has identified genes that make certain children more susceptible to invasive bacterial infections by performing a large genome-wide association study in African children. Dr Anna Rautanen from Adrian Hill's research group at the Wellcome Trust Centre for Human Genetics, said: 'Critically, the genetic variants we have identified carry a doubled risk of developing bacteraemia when infected with the Streptococcus pneumoniae bacteria. This discovery therefore provides clues in the pressing search for new ways to target the disease.'

News Archive

Seminars

Prof Robert Sauerwein: Title TBC, 28/Sep/2016 12:00

Prof Gavin Screaton: Title TBC, 13/Oct/2016 13:30

All Seminars

Clinical Trials

Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.

If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.

Jenner Institute Podcasts

jenner-podcast-home

See all Jenner podcasts

Recent Publications

Viral vectors as vaccine platforms: from immunogenicity to impact. Curr Opin Immunol, 41. Article

Cytokine profiles during invasive nontyphoidal Salmonella disease predict outcome in African children. Clin Vaccine Immunol. Article